Table 4.

Most common (occurring in at least 30% of patients) AEs (n = 60) and comparison of rates of grade 3/4 AEs in the first 2 cycles versus in the third cycle onward and in patients aged less than 75 years versus in patients aged 75 years or more



Overall toxicities

Grade 3/4 AEs by treatment cycle

Grade 3/4 AEs by patient age
AE
All grades, %
Grade 3/4, %
First and second cycles, %
Third cycle onward, %
Less than 75 y, %
75 y or more, %
Anemia   86   10   8   0   5   16  
Thrombocytopenia   93   51   33   17   52   50  
Infection   75   16   12   4   5   25  
Neutropenia   85   43   33   24   36   50  
Asthenia   63   5   4   2   0   12  
Nausea   55   2   2   0   0   4  
Diarrhea   55   16   8   2   17   16  
Peripheral neuropathy   55   17   8   6   14   25  
Constipation   52   8   6   2   3   16  
Anorexia   38   2   2   0   0   4  
Vomiting
 
30
 
2
 
2
 
0
 
0
 
4
 


Overall toxicities

Grade 3/4 AEs by treatment cycle

Grade 3/4 AEs by patient age
AE
All grades, %
Grade 3/4, %
First and second cycles, %
Third cycle onward, %
Less than 75 y, %
75 y or more, %
Anemia   86   10   8   0   5   16  
Thrombocytopenia   93   51   33   17   52   50  
Infection   75   16   12   4   5   25  
Neutropenia   85   43   33   24   36   50  
Asthenia   63   5   4   2   0   12  
Nausea   55   2   2   0   0   4  
Diarrhea   55   16   8   2   17   16  
Peripheral neuropathy   55   17   8   6   14   25  
Constipation   52   8   6   2   3   16  
Anorexia   38   2   2   0   0   4  
Vomiting
 
30
 
2
 
2
 
0
 
0
 
4
 

or Create an Account

Close Modal
Close Modal